Conjugated Hyperbilirubinemia
Determining the cause of unconjugated hyperbilirubinemia rarely poses difficulty. Usually, the major difficulty in evaluating jaundice is encountered in differentiating an intrahepatic excretion defect from obstruction in a patient with predominantly conjugated hyperbilirubinemia. This clinical situation is often described as cholestatic jaundice, and the approach to its differential diagnosis is discussed in detail below.
Cholestasis implies that, clinically and biochemically, there is impairment of bile formation or flow. Typically, a patient with cholestatic jaundice has predominantly conjugated hyperbilirubinemia and an elevated alkaline phosphatase, usually to at least three to four times normal. When prolonged, cholestasis may lead to hypercholesterolemia, fat and fat-soluble vitamin malabsorption, and retention of bile salts, which may lead to pruritus. Biochemical evidence of liver cell damage (elevated transaminases, prolonged prothrombin time uncorrected by administration of vitamin K) may be minimal or marked, depending upon the cause of the cholestasis. An important corollary is that all the features of cholestasis may be present in some patients without jaundice.
Impaired Hepatic Excretion. This pathogenetic category of jaundice, also called intrahepatic cholestasis, is applied to all disorders in the transport of conjugated bilirubin from the hepatocyte up to the radiologically visible bile ducts. Thus it includes a wide range of conditions from drug-induced cholestasis (impaired canalicular transport) to primary biliary cirrhosis (destruction of the small intrahepatic bile ductules). The following are some important causes of intrahepatic cholestasis.
Drug-induced Cholestasis. Typical cholestatic jaundice may be produced by phenothiazines, oral contraceptives, and methyltestosterone. Eosinophilia may accompany drug-induced jaundice.
Sepsis. Systemic sepsis, mainly due to gram-negative organisms, may produce a predominantly conjugated hyperbilirubinemia, usually accompanied by mild elevation of serum alkaline phosphatase levels.
Post-operative Jaundice. This increasingly recognized syndrome has an incidence of 15 per cent following heart surgery and 1 per cent following elective abdominal surgery. Occurring one to ten days postoperatively, the jaundice is multifactorial in origin but predominantly of the conjugated variety with increased alkaline phosphatase and minimally abnormal transaminases.
Hepatocellular Disease. Hepatocellular disease (i.e., hepatitis and cirrhosis) from a variety of causes (see Chapters 44 and 46) may result in a typical cholestatic jaundice. Evidence of hepatocellular damage and dysfunction is usually prominent and includes marked elevation of transaminases, prolonged prothrombin time, hypoalbuminemia, and clinical features of hepatic dysfunction (see Chapter 45). In hepatocellular disease there is interference with all three steps of hepatic bilirubin metabolism. Excretion, the rate-limiting step, is usually the most’ profoundly disturbed, leading to a predominantly conjugated hyperbilirubinemia. Jaundice may be profound in acute hepatitis (see Chapter 44) without prognostic implications. On the contrary, in chronic liver disease, jaundice is a sign that usually implies severe decompensation of hepatic function with a poor prognosis.
Extrahepatic Biliary Obstruction. Complete or partial obstruction of the extrahepatic bile ducts may result from a variety of causes, including impaction of gallstones, carcinoma of the head of the pancreas, tumors of the bile ducts, bile duct strictures, and chronic pancreatitis with bile duct compression. In complete obstruction, conjugated hyperbilirubinemia is prominent and usually plateaus at 30 to 40 mg/dl in the absence of renal failure, hepatocellular damage, or infection within the bile ducts, all of which may antedate or develop during the course of mechanical obstruction. Stools may become clay colored as a result of the failure of bile to enter the intestine. In partial obstruction, jaundice may be mild or even absent, becoming prominent when infection of the ducts complicates the obstruction.
- CHROMIC PANCREATITIS
- Conjugated Hyperbilirubinemia
- Aspiration Pneumonia and Lung Abscess
- BRORICHODILATORS
- CLINICAL TESTS OF DIGESTION AND ABSORPTION
- TESTS OF HEPATIC FUNCTION
- RISK FACTORS
- Hypertrophic Cardiomyopathy
- Peutz-Jeghers Syndrome
- Urinary Tract Obstruction
- CARCINOMA OF THE PANCREAS - Clinical Manifestations
- PHYSICAL THERAPY AND REHABILITATION
- Renal Tubular Acidosis
- Nephrotic Glomerulopathies
- Determination of Kidney Anatomy and Renal Blood Flow
- AORTIC ARTERITIS
- NONPHARMACOLOGICAL THERAPY OF TACHYARRHYTHMIAS
- PATHOPHYSIOLOGY OF AIRWAY OBSTRUCTION
- THE SLEEP APNEA SYNDROME
- Gastrointestinal Tract
- Amyloidosis
- GROSS ANATOMY
- PLEURAL DISEASE
- ARRHYTHMIAS in ACUTE MYOCARDIAL MFARCTION
- CAUSES OF PULMONARY HYPERTENSION
- RENAL PHARMACOLOGY
- TREATMENT
- PERICARDIAL DISEASES - ACUTE PERICARDITIS
- ARTERIOSCLEROSIS OBLITERANS
- SPECIFIC PATHOGENIC ORGANISMS
- MEDICAL MANAGEMENT OF ANGINA
- SCREENING TESTS OF HEPATOBILIARY DISEASE
- RAYNAUD’S PHENOMENON
- THE BLOOD VESSELS STRUCTURE
- PHYSICAL EXAMINATION